Ads
related to: asco abstracts
Search results
Small Business - Shelby County Reporter | Shelby County Reporter
The Shelby County Reporter· 3 hours agoLive from ASCO 2024 | Oral Report Released Latest Data of Olverembatinib in SDH-Deficient GIST, Including a CBR of 92.3% PR Newswire SUZHOU, China and ROCKVILLE, Md., June ...
...Patients with Advanced or Recurrent TP53 Wild-Type Endometrial Cancer During 2024 ASCO Plenary...
The Sun Chronicle· 4 days agoThe data were presented in a special ASCO plenary series rapid abstract update session on June 1 at 12:30pm CT and simultaneously published in the Gynecologic ...
Dual Immunotherapy Improves Response Rates in Gynecologic Clear Cell Cancers
MedPage Today· 1 day agoAmong 14 patients who received nivolumab alone, there were two partial responses and no complete...
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 3 days agoJacobio Pharma Presents SHP2 Plus KRAS G12C Data at ASCO PR Newswire BEIJING and SHANGHAI and CHICAGO, June 1, 2024 BEIJING and SHANGHAI and CHICAGO, June 1, 2024 /PRNewswire ...
..., fulzerasib (KRAS G12C Inhibitor) in Combination with cetuximab, in a Late-breaking Abstract at...
Valley City Times Record· 3 days agoG12C inhibitor) in combination with cetuximab for first-line non-small cell lung cancer (NSCLC)...
ASCO: Novel CAR T therapy and shorter targeted the | Newswise
Newswise· 5 days agoThe novel anti-CD19 autologous chimeric antigen receptor (CAR) T cell therapy obecabtagene autoleucel (obe-cel) achieved durable remissions in 40% of patients with relapsed or refractory B-ALL ...
Small Business - Salisbury Post | Salisbury Post
The Salisbury Post· 20 hours agoCARsgen Presents Updated Results on Satri-cel in Nature Medicine and at 2024 ASCO PR Newswire SHANGHAI, June 4, 2024 SHANGHAI, June 4, 2024 /PRNewswire/ -- CARsgen Therapeutics ...
Antibody-Drug Conjugate Picks Up Another Win in HR+/HER2-low Breast Cancer
MedPage Today· 3 days agoThe trial also provided evidence supporting a new breast cancer subgroup, HER2-ultralow, reported...
ASCO: Proton therapy demonstrates advantages in Ph | Newswise
Newswise· 2 days agoThe results were presented today at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting by Steven Frank, M.D., professor of Radiation Oncology and executive ...
...Anti-CTLA-4 Monoclonal Antibody) in Combination with Sintilimab as Neoadjuvant Treatment of Colon...
KOIN News 6 Portland· 2 days agoThe abstract was selected for ASCO Daily News coverage.
Ad
related to: asco abstracts